Syndex Bio
Cambridge
About Syndex Bio
Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $31.0M
- Funding stage: Seed
- Last round: Seed (Feb 2026)
- Website: syndex.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/syndex-bio-9275 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.